Accordingly, GC resistance in T-ALL is often attributed to aberrant GR expression (decreased or null-expression, presence of non-functional GR isoforms), hypermethylation of genes coding for effector proteins (e.g., BIM), and overexpression of multidrug resistance proteins, MDR [8]. This evidence concerns the gene NR3C1 and acute lymphoblastic leukemia.